Subtyping intractable functional constipation in children using clinical and laboratory data in a classification

Yi-Hsuan Huang1,2, Chenjia Xie3, Chih-Yi Chou4

  • 1Department of Gastroenterology, Children's Hospital of Nanjing Medical University, Nanjing, China.

Insights

Machine learning accurately classifies pediatric intractable functional constipation (IFC) subtypes using questionnaires and hormone levels. The Light Gradient Boosting Machine (LGBM) model achieved 83.8% accuracy, aiding in early management of IFC in children.

Area of Science:

  • Pediatric Gastroenterology
  • Biomedical Informatics
  • Machine Learning Applications

Background:

  • Intractable functional constipation (IFC) in children leads to severe symptoms and reduced quality of life, persisting into adulthood.
  • Early and efficient subtyping of IFC into normal transit constipation (NTC), outlet obstruction constipation (OOC), and slow transit constipation (STC) is crucial for effective management.
  • Machine learning offers a promising approach for early IFC subtyping using validated questionnaires and serum gastrointestinal hormone concentrations.

Purpose of the Study:

  • To evaluate the efficacy of supervised machine learning models in classifying pediatric IFC subtypes.
  • To identify key clinical and biochemical variables for accurate IFC subtyping.
  • To compare the performance of different machine learning models for IFC classification.

Main Methods:

  • 101 children with IFC and 50 controls were analyzed.
  • Supervised machine learning models (SVM, Random Forest, LGBM) were employed to classify IFC subtypes.
  • Classification was based on symptom severity, quality of life, self-efficacy (questionnaires), and serum gastrointestinal hormone levels (ELISA).
  • Model accuracy was validated against radiopaque marker results.

Main Results:

  • The Light Gradient Boosting Machine (LGBM) model achieved the highest accuracy (83.8%) in classifying IFC subtypes.
  • Significant variables for classification included stool frequency, PAC-QOL satisfaction, SEFCQ emotional self-efficacy, motilin, and vasoactive intestinal peptide serum concentrations.
  • The LGBM model demonstrated high performance with precision (84.5%), recall (83.6%), F1-score (83.4%), and AUROC (0.89).

Conclusions:

  • Machine learning models, particularly LGBM, can efficiently classify pediatric IFC subtypes using clinical data and serum hormone levels.
  • This approach facilitates early and accurate diagnosis, improving the management of IFC in children.
  • Machine learning serves as a valuable tool for personalized treatment strategies in pediatric functional constipation.
Abstract

Related Concept Videos

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
203
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
242
Assessment of the Rectum and Anus01:25

Assessment of the Rectum and Anus

Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
300
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
495
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy01:26

Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy

This lesson explores three gastrointestinal imaging techniques: radionuclide testing, colonic transit studies, and virtual colonoscopy.
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
120
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
227